This month`s issue includes details of the new drug studies presented at The Conference on Retroviruses and Opportunistic Infections (CROI), from Abbvie, BMS, BMS/Janssen, and Gilead.
CROI:14 was recently held in Boston, MA, and this year there were quite a few presentations about hepatitis C and HIV/HCV coinfection.
Also included is an interesting article by Linda Porter, RN, entitled `HEALTHWISE: Hepatitis C, Harm Reduction, and Health`, which examines ways we can all reduce harm to our health, with a reminder that 7th April is World Health Day.
From the HCV Advocate website.
This month`s issue includes details of the new drug studies presented at The Conference on Retroviruses and Opportunistic Infections (CROI), from Abbvie, BMS, BMS/Janssen, and Gilead.
CROI:14 was recently held in Boston, MA, and this year there were quite a few presentations about hepatitis C and HIV/HCV coinfection.
Also included is an interesting article by Linda Porter, RN, entitled `HEALTHWISE: Hepatitis C, Harm Reduction, and Health`, which examines ways we can all reduce harm to our health, with a reminder that 7th April is World Health Day.
Link to newsletter...
http://www.hcvadvocate.org/news/newsLetter/2014/advocate0414.html